Pharmaceutical co. with gout treatment acquired by Takeda in $800M deal
Takeda Pharmaceutical Co. has agreed to acquire an East Coast pharmaceutical firm with a gout treatment as its lead drug in a deal valued at more than $800 million. Takeda said it made the deal to bolster its gout treatment portfolio. Takeda is one of the largest pharmaceuticals companies in Asia and is acquiring URL […]